title: Antibodies' long revenue stream spurs pharma acquisitions.
authors.forename: Peter
authors.initials: P
authors.lastname: Mitchell
mesh_terms: D000906:Antibodies / Q000191:economics* / Q000627:therapeutic use*; D004345:Drug Industry / Q000191:economics* / Q000639:trends*; D006801:Humans; D014481:United States
chemical_list: D000906:Antibodies